Mantle Therapeutics
PrivateLast Round
Seed
Nov 26, 2024
Total Funding Raised
$3.5M
Company Overview
Mantle Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in November 2024.
Mantle Therapeutics is a biotechnology company that develops treatments for rare fatal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mantle Therapeutics Comparables
Compare Mantle Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genevation LTD | 85% | |
| Nouscom | 79% | |
| Valo Therapeutics | 75% |
For institutional investors. Book with your work email.
Mantle Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Mantle Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RTW Investments | Seed |
| AIN Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 26, 2024
$4M round led by RTW Investments and AIN Ventures.
For institutional investors. Book with your work email.
Mantle Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mantle Therapeutics's valuation, stock price, and market status.
Is Mantle Therapeutics a public or private company?
Mantle Therapeutics is a private company.
What is the current stock price of Mantle Therapeutics?
Mantle Therapeutics is a private company, so its shares have no public market price. Caplight tracks Mantle Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mantle Therapeutics worth (valuation)?
Valuation information for Mantle Therapeutics is not publicly available.
Can I buy Mantle Therapeutics stock?
Mantle Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mantle Therapeutics's last funding round?
Mantle Therapeutics's most recent funding round was Seed on November 26, 2024.
Who are the main investors in Mantle Therapeutics?
Key investors in Mantle Therapeutics include RTW Investments, AIN Ventures.
Will Mantle Therapeutics IPO soon?
No public IPO plans have been announced for Mantle Therapeutics.
How can I track Mantle Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Mantle Therapeutics's shares on secondary markets.